Teratocarcinomas are tumors that arise from primordial germ cells and are readily curable with DNA-damaging chemotherapeutic drugs. Teratocarcinoma cells ex vivo in tissue culture are also relatively chemosensitive and undergo apoptotic death in response to DNA damage. We have previously hypothesized that the observed sensitivity of this tumor type to DNA damage is related to high basal expression of wild-type p53 protein. We have now addressed this issue by characterizing the DNA damage response of isogenic teratocarcinoma cells that dier only in their level of expression of wild-type p53 protein. We ®nd a clear p53 dose-response relationship in these cells for rapid apoptosis following DNA damage that correlates with diminished colony formation in clonogenic survival assays. These results suggest that strategies to increase basal wild-type p53 protein expression prior to treatment with DNA-damaging drugs may improve curability in other tumor types. Oncogene (2001) 20, 2982 ± 2986.
Keywords: p53; apoptosis; DNA damage; teratocarcinoma cells Testicular teratocarcinomas are the most common tumor in males between the ages of 15 and 35. Although most patients present with metastatic disease the overall survival rate with chemotherapy approaches 90%. The biological basis for this extreme sensitivity to DNA-damaging chemotherapeutic drugs is unclear at present (Lutzker and Barnard, 1998) . One important biological variable in the response of cancer cells to DNA damage is p53 status. In this regard testicular teratocarcinomas rarely contain p53 gene mutations and commonly express high levels of nuclear wild-type p53 protein (Lutzker, 1998) . Cell lines (both human and murine) derived from teratocarcinomas also express high levels of nuclear wild-type p53 protein (up to 43-fold higher than immortalized ®broblasts) (Chresta et al., 1996; Lutzker and Levine, 1996) . In the absence of genotoxic stresses the p53 in teratocarcinoma cells is in a transcriptionally inactive latent state (Lutzker and Levine, 1996) . DNA damage activates p53 in teratocarcinoma cells leading to enhanced expression of p53-regulated target genes which correlates with apoptotic death (Chresta et al., 1996; Lutzker and Levine, 1996) .
Although wild-type p53 in teratocarcinoma cells responds to DNA damage signals, the overall importance of wild-type p53 expression to the sensitivity of teratocarcinoma cells to DNA damage is still unclear. Experiments comparing non-isogenic teratocarcinoma cell lines have yielded con¯icting results (Houldsworth et al., 1998; Zamble et al., 1998) . Burger and colleagues compared parental NT2 teratocarcinoma cells with NT2 cells expressing human papilloma virus E6 protein and found no dierences in chemosensitivity (Burger et al., 1999) . However parental NT2 cells express low basal levels of p53 relative to most other teratocarcinoma cell lines (Burger et al., 1999) and clinical studies of germ cell tumors have demonstrated a positive correlation between degree of nuclear p53 immunoreactivity and response to treatment (Eid et al., 1997) . Therefore studies utilizing NT2 cells do not address the potentially important role of high level wild-type p53 expression for the sensitivity of teratocarcinoma cells to DNA damage.
To examine how p53 status and levels in teratocarcinoma cells contribute to the DNA damage response we have derived a panel of isogenic P19 murine teratocarcinoma cells with dierent basal levels of wild-type p53 protein expression. P19 murine teratocarcinoma cells normally lack p53 expression due to insertional inactivation at the p53 locus by a murine leukemia virus and loss of heterozygocity (Schmidt-Kastner et al., 1998) . Previous attempts to reconstitute stable wild-type p53 expression in these cells utilizing cDNA expression vectors have been unsuccessful (Schmidt-Kastner et al., 1998 and S Lutzker, personal observation) . Notably, we found signi®cant colony suppression when wild-type p53 cDNA expression vectors were stably transfected into P19 cells (data not shown). These results indicate that P19 cells are growth suppressed in response to nonphysiological expression of wild-type p53 in a manner similar to other p53-negative cell lines. To achieve more physiological p53 expression we transfected P19 cells with a 13.7 kilobase genomic fragment encompassing the entire murine p53 locus including endogenous promoter and enhancer elements upstream of exon 1 (Almon et al., 1993; Hale and Braithwaite, 1995; Roy and Reisman, 1996) . Co-transfection of this genomic fragment together with a neomycin-resistance plasmid (PGK-Neo) yielded a high frequency of P19 clones (greater than 30%) with stable p53 expression (data not shown). Four clones with stable p53 expression (clones 9, 10, 13 and 15) and one clone transfected with the neomycin-resistance plasmid alone (clone PGK) were chosen for further analysis. Clones 13 and 15 express high basal p53 protein levels (comparable to non-isogenic F9 teratocarcinoma cells) while clones 9 and 10 express much lower basal p53 protein levels (Figure 1a, lower panel) . Dierences in the level of basal p53 expression in these clones likely re¯ects the number of p53 genomic fragments correctly integrated and/or the site of integration. The p53 in these cells is nuclear (Figure 1b and data not shown) and not in complex with mdm2 ( Figure 1a , upper panels), resembling p53 expressed in non-isogenic F9 teratocarcinoma cells. The P19 clones with reconstituted p53 expression remained tumorigenic in syngeneic C3H/He mice and maintained p53 expression even after several months in culture (S Lutzker, personal observation).
A yeast-based assay (Flaman et al., 1995) indicates that p53 expressed in the P19 clones does not contain an inactivating mutation within the central DNA binding region (data not shown). To further analyse the functionality of the reconstituted p53 in the various P19 clones these cells were DNA damaged with the UV-mimetic drug 4NQO (Maltzman and Czyzyk, 1984) . Wild-type p53 levels commonly rise in cells following DNA damage due to diminished interaction with mdm2 (Shieh et al., 1997 (Shieh et al., , 1999 Unger et al., 1999) . Similarly wild-type p53 protein levels increased in all the P19 clones examined (Figure 2a) . This is most apparent in clones 9 and 10 which have a higher mdm2 to p53 ratio than clones 13 and 15 (Figure 1a) . Induction of p53 with 4NQO also resulted in p53-dependent p21 protein expression (Figure 2b ). P21 is a major downstream target of wild-type (but not mutant) p53 (El-Deiry et al., 1993) . The topoisomerase-II inhibitor drug etoposide also induced p53 and p21 protein expression in a similar manner in these cells (data not shown) indicating that the reconstituted p53 in P19 cells is functionally wild-type and responds to diverse DNA damage signals.
Morphologically there was very little change in the appearance of P19 cells lacking p53 expression (clone PGK) following exposure to 4NQO (Figure 3a) . In contrast clone 13 and 15 underwent a dramatic morphological response under the same conditions with a large number of cells rounding up and detaching from the tissue culture plate surface (Figure 3a and not shown). Electrophoresis of DNA isolated from thesē oating cells yielded a ladder pattern consistent with apoptotic death (Figure 3b ). P19 clones expressing low levels of wild-type p53 (clones 9 and 10) had a much less dramatic morphological response to 4NQO ( Figure  3a and not shown). Annexin V staining further con®rmed apoptotic death in the P19 clones with the extent of apoptosis correlating with basal wild-type p53 protein levels (Table 1) .
These results indicate that apoptosis in P19 cells in response to 4NQO is largely p53-dependent. However it is well recognized that extent of apoptosis does not necessarily correlate with overall sensitivity to DNA (421) or an anti-mdm2 (upper) monoclonal antibody (2A10) and analysed by Western blotting with a rabbit anti-p53 polyclonal antibody (FL-393 from Santa Cruz) or rabbit anti-mdm2 polyclonal antibody (gift of A Levine at Rockefeller University) as indicated. Bands were detected using an ECL kit (Amersham). F9 teratocarcinoma cells (Lutzker and Levine, 1996) , Val5 ®broblast cells (Wu et al., 1993) cultured at permissive (32) and non-permissive (37) temperatures for functional p53 and 3T3DM ®broblast cells with ampli®ed mdm-2 genes (Oliner et al., 1992) are included as controls. (b) Cells were ®xed with 50% acetone/50% methanol, blocked with normal goat serum and reacted with rabbit polyclonal anti-p53 antibody FL-393 followed by biotinylated F (ab')2 fragment of goat anti-rabbit antibody (Zymed) and streptavidin-FITC (Roche). Parental P19 cells gave undetectable p53 staining under these conditions (not shown) Oncogene A p53 dose-response in isogenic teratocarcinoma cells SG Lutzker et al damage (Brown and Wouters, 1999) . We therefore examined cell viability using an MTT assay ( Figure  4a ). P19 cells with high basal p53 expression were more sensitive to 4NQO than isogenic cells with low or no wild-type p53 protein expression. This was most apparent at low concentrations of 4NQO. Similar results were obtained using a Trypan-blue dye exclusion assay to determine cell viability (data not (Lutzker and Levine, 1996) . Lane 1=1 kilobase DNA markers (Gibco ± BRL) shown). Clonogenicity following exposure to 4NQO was assessed to determine long-term cell viability (Figure 4b) . At each drug concentration tested clonogenicity was reduced more in the high p53 expressing P19 clones relative to clones with no or low p53 expression.
Taken together these results are consistent with the hypothesis that high levels of wild-type p53 sensitize teratocarcinoma cells to DNA damage resulting in decreased cell viability. In this regard teratocarcinoma cells resemble their non-malignant counterpart, embryonic stem (ES) cells. ES cells express high levels of wild-type p53 protein which is required for rapid apoptosis and diminished cell viability following DNA damage (Corbet et al., 1999; Sabapathy et al., 1997) . Thus the curability of teratocarcinoma cells with DNA-damaging chemotherapeutic drugs may relate more to the target cell for transformation than the oncogenic changes present in the malignant clone.
P53 in teratocarcinoma cells has latent transcriptional activity which is reversed in response to DNA damage signals (Chresta et al., 1996; Lutzker and Levine, 1996) . This switch from latent to active p53 is readily apparent in the current study. P53 is clearly active in the low p53 expressing clones following DNA damage (Figures 2b, 3 and 4) even though p53 protein levels do not approach the basal level of p53 in the high p53 expressing clones (Figure 2a ). Teratocarcinoma cells resemble other embryonic cells that proliferate rapidly despite high level wild-type p53 expression (Schmid et al., 1991) . Importantly, high level wild-type p53 expression is required in teratocarcinoma cells for rapid loss of viability following low level DNA damage (Figure 4a ). High level wild-type p53 expression appears to be similarly required in non-transformed embryonic cells to sense genotoxic teratogens and prevent fetal malformations (Nicol et al., 1995) . The mechanism accounting for latent p53 in teratocarcinoma cells is currently under investigation. Cells were untreated or treated with 40 micromolar 4NQO for 8 h and per cent apoptosis at 24 h determined by Annexin V staining (PharMingen) and FACS analysis using a Becton-Dickinson FACScan Figure 4 High basal levels of wild-type p53 contribute to diminished cell viability in response to DNA damage. (a) Cells were plated in 96 well plates (1610 4 cells/well), allowed to adhere overnight and exposed to increasing concentrations of 4NQO for 72 h. MTT (Sigma) was added to a ®nal concentration of 0.25 mg/ml and absorption recorded at 570 nm. Six duplicate wells were analysed for each drug concentration and per cent survival relative to time 0 graphed. Error bars indicate standard deviation. Similar results were obtained in an independent experiment. (b) Cells were plated in 10 cm plates (5000 cells/plate) and allowed to adhere overnight. Cells were exposed to variable concentrations of 4NQO for 8 h and colonies scored 7 days later by staining with 1% Coumassie dissolved in 50% methanol/50% PBS. Similar results were obtained in an independent experiment
